Lannett Company
LCI
#10382
Rank
S$9.56 M
Marketcap
S$0.89
Share price
0.00%
Change (1 day)
-70.89%
Change (1 year)

Revenue for Lannett Company (LCI)

Revenue in 2023 (TTM): S$0.42 Billion

According to Lannett Company's latest financial reports the company's current revenue (TTM ) is S$0.40 Billion. In 2022 the company made a revenue of S$0.41 Billion a decrease over the revenue in the year 2021 that were of S$0.54 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lannett Company from 2000 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) S$0.42 B3.1%
2022 S$0.41 B-24.72%
2021 S$0.54 B-23.47%
2020 S$0.71 B-6.59%
2019 S$0.76 B-18.94%
2018 S$0.94 B10.07%
2017 S$0.86 B-10.5%
2016 S$0.96 B57.48%
2015 S$0.61 B25.42%
2014 S$0.48 B99.97%
2013 S$0.24 B44.16%
2012 S$0.16 B20.85%
2011 S$0.13 B-9.85%
2010 S$0.15 B-11.12%
2009 S$0.17 B32.53%
2008 S$0.13 B25.81%
2007 S$0.10 B-14.72%
2006 S$0.12 B60.87%
2005 S$76.32 M-24.44%
2004 S$0.10 B12.23%
2003 S$90 M48.32%
2002 S$60.68 M87.25%
2001 S$32.4 M91.85%
2000 S$16.89 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
S$81.36 B 20,109.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$119.41 B 29,561.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$56.81 B 14,012.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$73.05 B 18,045.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
S$54.88 B 13,532.77%๐Ÿ‡ฌ๐Ÿ‡ง UK